EPLIN downregulation promotes epithelial–mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis
Open Access
- 30 May 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 30 (50), 4941-4952
- https://doi.org/10.1038/onc.2011.199
Abstract
Epithelial–mesenchymal transition (EMT) is a crucial mechanism for the acquisition of migratory and invasive capabilities by epithelial cancer cells. By conducting quantitative proteomics in experimental models of human prostate cancer (PCa) metastasis, we observed strikingly decreased expression of EPLIN (epithelial protein lost in neoplasm; or LIM domain and actin binding 1, LIMA-1) upon EMT. Biochemical and functional analyses demonstrated that EPLIN is a negative regulator of EMT and invasiveness in PCa cells. EPLIN depletion resulted in the disassembly of adherens junctions, structurally distinct actin remodeling and activation of β-catenin signaling. Microarray expression analysis identified a subset of putative EPLIN target genes associated with EMT, invasion and metastasis. By immunohistochemistry, EPLIN downregulation was also demonstrated in lymph node metastases of human solid tumors including PCa, breast cancer, colorectal cancer and squamous cell carcinoma of the head and neck. This study reveals a novel molecular mechanism for converting cancer cells into a highly invasive and malignant form, and has important implications in prognosis and treating metastasis at early stages.Keywords
This publication has 53 references indexed in Scilit:
- Dynamics and interplay of nuclear architecture, genome organization, and gene expressionGenes & Development, 2007
- Structure and Mechanism of Cadherins and Catenins in Cell-Cell ContactsAnnual Review of Cell and Developmental Biology, 2007
- Protein 4.1B suppresses prostate cancer progression and metastasisProceedings of the National Academy of Sciences, 2007
- Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic processBMC Cancer, 2007
- cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasisOncogene, 2007
- Proteomic Identification of Biomarkers in the Cerebrospinal Fluid (CSF) of Astrocytoma PatientsJournal of Proteome Research, 2007
- Proteomic identification of the wt-p53-regulated tumor cell secretomeOncogene, 2006
- Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasisThe Prostate, 2006
- Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins.Endocrine, Metabolic & Immune Disorders - Drug Targets, 2006
- Changes in Cytoskeletal Protein Composition Indicative of an Epithelial-Mesenchymal Transition in Human Micrometastatic and Primary Breast Carcinoma CellsClinical Cancer Research, 2005